EUVIMEDEUVIMED entdecken
Crossref

Endoscopic Ultrasound-Guided Radiofrequency Ablation for Pancreatic Insulinomas: A Leap Towards Non-Surgical Management

J. Maurer, T. Pachofszky, P. Holzmüller, C. Madl, N. Pfisterer

Zeitschrift für Gastroenterologie · 01.05.2024 · 62 (05) · e485

DOI: 10.1055/s-0044-1786900 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Zeitschrift für Gastroenterologie, erschienen am 01.05.2024. Verfasst von J. Maurer und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Insulinomas, the most prevalent type of functioning pancreatic neuroendocrine tumors, necessitate intervention due to complications stemming from excessive insulin release. While surgical excision stands as the conventional remedy, it's marred by a considerable incidence of negative outcomes. An alternative, Endoscopic Ultrasound-Guided Radiofrequency Ablation (EUS-RFA), has shown promising prospects regarding both safety and effectiveness in handling these neoplasms. This study ventures into the realm of EUS-RFA, spotlighting its application as a less invasive treatment modality for patients bearing pancreatic insulinomas deemed unsuitable for surgical intervention. Materials and methods: This is a single-center, retrospective analysis that includes all consecutive patients with functioning pancreatic insulinoma who underwent EUS-RFA due to surgical unfitness or refusal to undergo complete surgical resection, between July 2019 and January 2024. The evaluation focused on several key outcomes: the effectiveness of the ablation in entirely removing the mass, the frequency of EUS-RFA sessions, severity, and rate of adverse events, and clinical outcomes. This includes whether symptoms were alleviated alongside normalization of blood glucose levels. Follow-up post-procedure after the procedure was also meticulously monitored to assess these factors.

Results

A total of 4 patients (mean age: 57±24.42 years; F:M 1:3) were included. The mean size of insulinoma was 13.75mm±7.63 mm. All patients attained technical success and clinical remission. A two-session RFA strategy was effectively employed in one case (25%), while another required an EUS-guided open surgical approach due to the lesion's closeness to blood vessels. There were two (50%) early adverse events linked to the procedures, one of which involved mild pancreatitis. The individual who underwent surgical ablation developed a peripancreatic hematoma that necessitated additional surgical attention in the sense of a surgical revision due to pancreatic fistula and a pancreatic hematoma. Fortunately, except for the individual who received open surgical RFA, no major complications, such as death or surgical interventions, were reported. Following an average monitoring period of 6.1 months, all patients were evaluated for symptom relief and sustained normal blood glucose levels.

Conclusions

In summary, our study's findings advocate for Endoscopic Ultrasound-Guided Radiofrequency Ablation (EUS-RFA) as an efficacious and relatively safe alternative to surgical resection in the management of small pancreatic insulinomas. With a small cohort, we achieved complete remission in all patients, signifying its potential as a viable treatment modality. Publication History Article published online: 05 June 2024 © 2024. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

Zitieren

APA

Maurer, J., Pachofszky, T., Holzmüller, P., Madl, C., & Pfisterer, N. (2024). Endoscopic Ultrasound-Guided Radiofrequency Ablation for Pancreatic Insulinomas: A Leap Towards Non-Surgical Management. Zeitschrift für Gastroenterologie, 62(05), e485. https://doi.org/10.1055/s-0044-1786900

Vancouver

Maurer J, Pachofszky T, Holzmüller P, Madl C, Pfisterer N. Endoscopic Ultrasound-Guided Radiofrequency Ablation for Pancreatic Insulinomas: A Leap Towards Non-Surgical Management. Zeitschrift für Gastroenterologie. 2024;62(05):e485. doi:10.1055/s-0044-1786900

BibTeX
@article{Maurer2024,
  author = {Maurer, J. and Pachofszky, T. and Holzmüller, P. and Madl, C. and Pfisterer, N.},
  title = {Endoscopic Ultrasound-Guided Radiofrequency Ablation for Pancreatic Insulinomas: A Leap Towards Non-Surgical Management},
  journal = {Zeitschrift für Gastroenterologie},
  year = {2024},
  volume = {62},
  number = {05},
  pages = {e485},
  doi = {10.1055/s-0044-1786900}
}
Kostenlos starten →